key: cord-0986391-63qlkhev authors: Lim, Soo; Bae, Jae Hyun; Kwon, Hyuk-Sang; Nauck, Michael A. title: Reply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19 date: 2021-01-18 journal: Nat Rev Endocrinol DOI: 10.1038/s41574-021-00467-4 sha: ab2982323c5b9746b1f7865fccafd781753316dc doc_id: 986391 cord_uid: 63qlkhev nan with underlying inflammation, can induce overactivation of sympathetic functions, and this sympathetic dominance can disturb the balance within the autonomic nervous system 12 . This alteration is probably unfav ourable for cardiometabolic health, and potentially leads to worse outcomes and increased mortality. Thus, COVID-19 can be a triggering factor that initiates the harmful development of cardiorespiratory distress and, in particular in patients characterized by sympathetic overactivity, might lead to multiorgan failure. We fully agree with Boccardi 2 that early identification of autonomic imbalance is critical in patients with diabetes mellitus to concentrate therapeutic measures on those at risk of deteriorating health. We also agree that the autonomic nervous system interacts with the immune system via neuroinflammatory pathways, which eventually might affect the function of cardiac and respiratory systems 13 . Moreover, we agree that therapeutic modulation of a disturbed autonomic nervous system to achieve an improved balance might improve the prognosis of COVID-19 in patients with diabetes mellitus. Although more evidence is needed, various methods, such as non-invasive electrical stimulation on the vagal nerve system, offer useful potential along these lines 14 . Thus, it has been reported that vagus nerve stimulation in the auricular area could be an effective modality to improve the acute respiratory distress conditions seen in patients with COVID-19 (ref. 15 ). As of 13 January 2021, the World Health Organization reports (see Related links) that more than 91 million people have been infected with SARS-CoV-2 worldwide, and of those, 1.9 million have died. Fortunately, vaccines have been developed (see Related links) and are currently being administered to people at high risk, such as the elderly and medical personnel. Before the vaccination programme becomes effective, people at high risk of COVID-19, such as those with diabetes mellitus, cardiovascular diseases or immunocompromised disorders, should receive priority attention and treatment if they contract COVID-19. We hope that further medical approaches will be discovered to COVID-19 and diabetes mellitus: from pathophysiology to clinical management Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19 Risk factors for the presence and progression of cardiovascular autonomic neuropathy in type 2 diabetes: ADDITION-Denmark Sympathetic activation: a potential link between comorbidities and COVID-19 Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies Adiponectin, TNF-alpha and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis Cytokines and atherosclerosis: a comprehensive review of studies in mice Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes Autonomic balance determines the severity of COVID-19 courses Neuroimmune interactions in cardiovascular diseases Celiac vagus nerve stimulation recapitulates angiotensin ii-induced splenic noradrenergic activation, driving egress of CD8 effector cells Non-invasive auricular vagus nerve stimulation as a potential treatment for covid19-originated acute respiratory distress syndrome The authors declare no competing interests.